JOHNSON & JOHNSON MANAGEMENT LIMITED

1. JOHNSON & JOHNSON MANAGEMENT LIMITED 1988-01-04 → present
2. JOHNSON & JOHNSON LIMITED 1925-02-02 → 1988-01-04

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company has prepared the financial statements on a going concern basis. The Directors believe it is reasonable to assume that the Company will have adequate resources for a period of 12 months (the "Assessment Period") from the date of approval of these financial statements to discharge its obligations as they fall due. The Directors have a reasonable expectation that the Company has sufficient resources to continue in operational existence for the foreseeable future.”

Group structure

1. JOHNSON & JOHNSON MANAGEMENT LIMITED · parent
   1. Johnson & Johnson Medical Limited 100% · Scotland · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   2. Johnson & Johnson Innovation Limited 100% · England · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   3. Johnson & Johnson Finance Limited 100% · England · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   4. Johnson & Johnson UK Treasury Company Limited 100% · England · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   5. Johnson & Johnson (Ireland) Ltd 100% · Ireland · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   6. GH Biotech Holdings Limited 19% · Ireland · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.
   7. Cilag Holding AG 100% · Switzerland · The principal activities of the investments are the development, manufacture and sale of healthcare, pharmaceutical products and medical devices, with the remainder of the investments functioning as holding companies.

Significant events

• “In June 2025, dividends were received in the amount of £519,117,253 from GH Biotech. The company paid dividends to the immediate parent entity, JJHC LLC, in the amount of £519,117,253 in June 2025.”
• “In June 2025, dividends were received in the amount of £3,670,667,694 from Cilag Holding AG. The company paid dividends to the immediate parent entity, JJHC LLC, in the amount of £3,670,667,694 in June 2025.”
• “On 14th October 2025, Johnson & Johnson announced its intention to separate its orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders. The separation process is expected to be completed in 18-24 months, subject to legal requirements, regulatory approvals and other customary conditions and approvals. This change will impact the Company's investment portfolio.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  +2%

  £50,000 → £51,000

• Net assets

  -8.5%

  £78,759,438,000 → £72,086,024,000

• Employees

  —

  Not reported

• Operating profit

  -14.8%

  -£244,000 → -£280,000

• Profit before tax

  -107.7%

  -£1,048,979,000 → -£2,178,900,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers